Enoxaparin
Preparation of Chitosan Nanoparticles for Simultaneous Drug Delivery of Dacarbazine and Enoxaparin in Melanoma
Apixaban Versus Enoxaparin for Thromboprophylaxis After Knee Replacement (ADVANCE-2): A Randomised Double-Blind Trial
Efficacy and Safety of the Low-Molecular Weight Heparin Enoxaparin Compared With Unfractionated Heparin Across the Acute Coronary Syndrome Spectrum: A Meta-Analysis.
Secondary Prevention of Venous Thromboembolic Events in Patients With Active Cancer: Enoxaparin Alone Versus Initial Enoxaparin Followed by Warfarin for a 180-Day Period
Administering an enoxaparin injection
Extended Duration Rivaroxaban Versus Short-Term Enoxaparin for the Prevention of Venous Thromboembolism After Total Hip Arthroplasty: A Double-Blind, Randomised Controlled Trial
Intravenous Enoxaparin or Unfractionated Heparin in Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction: The International Randomised Open-Label ATOLL Trial
Rivaroxaban Versus Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty (RECORD4): A Randomised Trial